회사 부채 증권
아래는 최저 수익률 기준으로 정렬된 Novartis AG Sponsored ADR 채권 목록입니다. 투자자들은 시장 변동성이 있는 시기에 더 높은 안정성을 이유로 종종 한 회사의 채권을 선택합니다. 가격, 수익률 및 기타 통계를 살펴보고 신뢰할 수 있는 투자를 찾아보세요.
심볼 | 채권 최저 수익률 % | 가격 % | 쿠폰 % | 머튜어리티 데이트 | 미결제 금액 | 액면가 | S&P 등급 | 피치 등급 | 발행자 |
|---|---|---|---|---|---|---|---|---|---|
| NNVS6224266Novartis Capital Corp. 5.3% 05-NOV-2055 | 5.98% | 90.61% | 5.300% | 2055-11-05 | 550 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342132Novartis Capital Corp. 5.7% 18-MAR-2056 | 5.95% | 96.42% | 5.700% | 2056-03-18 | 2.25 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 5.93% | 83.22% | 4.700% | 2054-09-18 | 750 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342130Novartis Capital Corp. 5.6% 18-MAR-2046 | 5.90% | 96.48% | 5.600% | 2046-03-18 | 1 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAS7Novartis Capital Corp. 2.75% 14-AUG-2050 | 5.87% | 60.06% | 2.750% | 2050-08-14 | 1.25 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224265Novartis Capital Corp. 5.2% 05-NOV-2045 | 5.80% | 93.00% | 5.200% | 2045-11-05 | 350 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAH1Novartis Capital Corp. 4.4% 06-MAY-2044 | 5.79% | 84.63% | 4.400% | 2044-05-06 | 1.85 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| XXPNDNovartis Capital Corp. 4.0% 20-NOV-2045 | 5.79% | 79.33% | 4.000% | 2045-11-20 | 1.25 B USD | 1,000.00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 5.68% | 79.23% | 3.700% | 2042-09-21 | 500 M USD | 1,000.00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS6342131Novartis Capital Corp. 4.9% 18-MAR-2036 | 5.31% | 96.94% | 4.900% | 2036-03-18 | 2.25 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224264Novartis Capital Corp. 4.6% 05-NOV-2035 | 5.23% | 95.44% | 4.600% | 2035-11-05 | 925 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 5.06% | 94.30% | 4.200% | 2034-09-18 | 1.1 B USD | 1,000.00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS6342137Novartis Capital Corp. 4.6% 18-MAR-2033 | 5.05% | 97.47% | 4.600% | 2033-03-18 | 2 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224263Novartis Capital Corp. 4.3% 05-NOV-2032 | 4.89% | 96.83% | 4.300% | 2032-11-05 | 925 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342136Novartis Capital Corp. 4.4% 18-MAR-2031 | 4.84% | 98.22% | 4.400% | 2031-03-18 | 1.75 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224251Novartis Capital Corp. 4.1% 05-NOV-2030 | 4.79% | 97.38% | 4.100% | 2030-11-05 | 1.75 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAR9Novartis Capital Corp. 2.2% 14-AUG-2030 | 4.72% | 90.95% | 2.200% | 2030-08-14 | 1.5 B USD | 1,000.00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 4.71% | 96.81% | 4.000% | 2031-09-18 | 850 M USD | 1,000.00 USD | AA− | AA- | Novartis Capital Corp. |
| NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 4.55% | 97.85% | 3.800% | 2029-09-18 | 1 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342135Novartis Capital Corp. 4.1% 16-MAR-2029 | 4.53% | 98.97% | 4.100% | 2029-03-16 | 1.25 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6224255Novartis Capital Corp. 3.9% 05-NOV-2028 | 4.45% | 98.84% | 3.900% | 2028-11-05 | 700 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| UUS66989HAN8Novartis Capital Corp. 3.1% 17-MAY-2027 | 4.14% | 99.28% | 3.100% | 2027-05-17 | 1 B USD | 1,000.00 USD | AA− | AA- | Novartis Capital Corp. |
| XXS336624860Novartis Finance S.A. 4.0% 13-MAY-2041 | 4.09% | 98.90% | 4.000% | 2041-05-13 | 500 M EUR | 1,000.00 EUR | AA− | — | Novartis Finance SA |
| NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 3.98% | 99.05% | 2.000% | 2027-02-14 | 1.25 B USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| XXS336624851Novartis Finance S.A. 3.5% 13-MAY-2035 | 3.77% | 98.04% | 3.500% | 2035-05-13 | 600 M EUR | 1,000.00 EUR | AA− | — | Novartis Finance SA |
| XXS176904160Novartis Finance S.A. 1.7% 14-AUG-2038 | 3.76% | 80.36% | 1.700% | 2038-08-14 | 750 M EUR | 1,000.00 EUR | AA− | AA- | Novartis Finance SA |
| XXS336624827Novartis Finance S.A. 3.1% 13-JAN-2032 | 3.47% | 98.19% | 3.100% | 2032-01-13 | 600 M EUR | 1,000.00 EUR | AA− | — | Novartis Finance SA |
| XXS149282548Novartis Finance S.A. 0.625% 20-SEP-2028 | 3.14% | 95.03% | 0.625% | 2028-09-20 | 500 M EUR | 1,000.00 EUR | AA− | AA- | Novartis Finance SA |
| XXS176904119Novartis Finance S.A. 1.375% 14-AUG-2030 | 3.12% | 93.55% | 1.375% | 2030-08-14 | 750 M EUR | 1,000.00 EUR | AA− | AA- | Novartis Finance SA |
| NNOJANovartis Finance S.A. 1.125% 30-SEP-2027 | 2.73% | 98.29% | 1.125% | 2027-09-30 | 600 M EUR | 1,000.00 EUR | AA− | AA- | Novartis Finance SA |
| XXS113472979Novartis Finance S.A. 1.625% 09-NOV-2026 | 2.72% | 99.77% | 1.625% | 2026-11-09 | 600 M EUR | 1,000.00 EUR | AA− | AA- | Novartis Finance SA |
 NOV245Novartis AG 1.85% 18-JUN-2049 | 1.45% | 107.60% | 1.850% | 2049-06-18 | 190 M CHF | 5,000.00 CHF | AA− | AA- | Novartis AG |
| NOV244Novartis AG 1.85% 18-JUN-2040 | 1.33% | 106.53% | 1.850% | 2040-06-18 | 280 M CHF | 5,000.00 CHF | AA− | AA- | Novartis AG |
| NOV152Novartis AG 1.05% 11-MAY-2035 | 1.05% | 100.03% | 1.050% | 2035-05-11 | 325 M CHF | 5,000.00 CHF | AA− | AA- | Novartis AG |
| CH135325782Novartis AG 1.75% 16-JUN-2034 | 0.98% | 105.72% | 1.750% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | AA− | AA- | Novartis AG |
| A3LZ2RNovartis AG 1.65% 18-JUN-2031 | 0.78% | 104.07% | 1.650% | 2031-06-18 | 435 M CHF | 5,000.00 CHF | AA− | AA- | Novartis AG |
| NOV151Novartis AG 0.625% 13-NOV-2029 | 0.62% | 100.03% | 0.625% | 2029-11-13 | 550 M CHF | 5,000.00 CHF | AA− | AA- | Novartis AG |
| CH135325780Novartis AG 1.6% 18-JUN-2027 | 0.22% | 101.12% | 1.600% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | AA− | AA- | Novartis AG |
| XXS223599621Novartis Finance S.A. 0.0% 23-SEP-2028 | — | 93.80% | 0.000% | 2028-09-23 | 1.85 B EUR | 1,000.00 EUR | AA− | AA- | Novartis Finance SA |
| NNVS6224271Novartis Capital Corp. FRN 05-NOV-2028 | — | 100.07% | 4.156% | 2028-11-05 | 800 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |
| NNVS6342134Novartis Capital Corp. FRN 16-MAR-2029 | — | 100.45% | 4.288% | 2029-03-16 | 500 M USD | 1,000.00 USD | AA− | — | Novartis Capital Corp. |